Viewing Study NCT00456794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-28 @ 12:04 AM
Study NCT ID: NCT00456794
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2007-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Sponsor: Kyowa Kirin, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module